Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Murthy

Showing results (781-790 of 873) with videos related to

Pageof 88
Sort By:
Journal of Virology|July 30, 2005
Replicating rather than nonreplicating adenovirus-human immunodeficiency virus recombinant vaccines are better at eliciting potent cellular immunity and priming high-titer antibodiesBo Peng, Liqun Rejean Wang, Victor Raúl Gómez-Román, et al.
Infection Control and Hospital Epidemiology|June 5, 2024
SHEA position statement on pandemic preparedness for policymakers: pandemic data collection, maintenance, and releaseWestyn Branch-Elliman, David B Banach, Lynne J Batshon, et al.
The American Journal of Gastroenterology|January 3, 2020
Longitudinal Trends in the Direct Costs and Health Care Utilization Ascribable to Inflammatory Bowel Disease in the Biologic Era: Results From a Canadian Population-Based AnalysisLaura E Targownik, Gilaad G Kaplan, Julia Witt, et al.
Inflammatory Bowel Diseases|October 23, 2018
Appropriateness of Biologics in the Management of Crohn's Disease Using RAND/UCLA Appropriateness MethodologyAdam V Weizman, Geoffrey C Nguyen, Cynthia H Seow, et al.
Journal of the Canadian Association of Gastroenterology|November 10, 2021
Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Risk Factors and MedicationsLaura E Targownik, Charles N Bernstein, Peter L Lakatos, et al.
Scientific Reports|August 26, 2015
Glycosyltransferase ST6GAL1 contributes to the regulation of pluripotency in human pluripotent stem cellsYu-Chieh Wang, Jason W Stein, Candace L Lynch, et al.
The Journal of Infectious Diseases|January 1, 1996
Protection of MN-rgp120-immunized chimpanzees from heterologous infection with a primary isolate of human immunodeficiency virus type 1P W Berman, K K Murthy, T Wrin, et al.
British Journal of Pharmacology|May 17, 2023
BQ788 reveals glial ET<sub>B</sub> receptor modulation of neuronal cholinergic and nitrergic pathways to inhibit intestinal motility: Linked to postoperative ileusElvio Mazzotta, Iveta Grants, Egina Villalobos-Hernandez, et al.
Journal of the Canadian Association of Gastroenterology|November 10, 2021
Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Seniors With IBDCharles N Bernstein, Harminder Singh, Sanjay K Murthy, et al.
Journal of the Canadian Association of Gastroenterology|November 10, 2021
Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Health Care Delivery During the Pandemic and the Future Model of Inflammatory Bowel Disease CareJennifer L Jones, Eric I Benchimol, Charles N Bernstein, et al.
Pageof 88

Showing results (781-790 of 873) with videos related to

Sort By:
Pageof 88
Journal of Virology|July 30, 2005
Replicating rather than nonreplicating adenovirus-human immunodeficiency virus recombinant vaccines are better at eliciting potent cellular immunity and priming high-titer antibodiesBo Peng, Liqun Rejean Wang, Victor Raúl Gómez-Román, et al.
Infection Control and Hospital Epidemiology|June 5, 2024
SHEA position statement on pandemic preparedness for policymakers: pandemic data collection, maintenance, and releaseWestyn Branch-Elliman, David B Banach, Lynne J Batshon, et al.
The American Journal of Gastroenterology|January 3, 2020
Longitudinal Trends in the Direct Costs and Health Care Utilization Ascribable to Inflammatory Bowel Disease in the Biologic Era: Results From a Canadian Population-Based AnalysisLaura E Targownik, Gilaad G Kaplan, Julia Witt, et al.
Inflammatory Bowel Diseases|October 23, 2018
Appropriateness of Biologics in the Management of Crohn's Disease Using RAND/UCLA Appropriateness MethodologyAdam V Weizman, Geoffrey C Nguyen, Cynthia H Seow, et al.
Journal of the Canadian Association of Gastroenterology|November 10, 2021
Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Risk Factors and MedicationsLaura E Targownik, Charles N Bernstein, Peter L Lakatos, et al.
Scientific Reports|August 26, 2015
Glycosyltransferase ST6GAL1 contributes to the regulation of pluripotency in human pluripotent stem cellsYu-Chieh Wang, Jason W Stein, Candace L Lynch, et al.
The Journal of Infectious Diseases|January 1, 1996
Protection of MN-rgp120-immunized chimpanzees from heterologous infection with a primary isolate of human immunodeficiency virus type 1P W Berman, K K Murthy, T Wrin, et al.
British Journal of Pharmacology|May 17, 2023
BQ788 reveals glial ET<sub>B</sub> receptor modulation of neuronal cholinergic and nitrergic pathways to inhibit intestinal motility: Linked to postoperative ileusElvio Mazzotta, Iveta Grants, Egina Villalobos-Hernandez, et al.
Journal of the Canadian Association of Gastroenterology|November 10, 2021
Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Seniors With IBDCharles N Bernstein, Harminder Singh, Sanjay K Murthy, et al.
Journal of the Canadian Association of Gastroenterology|November 10, 2021
Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Health Care Delivery During the Pandemic and the Future Model of Inflammatory Bowel Disease CareJennifer L Jones, Eric I Benchimol, Charles N Bernstein, et al.
Pageof 88